$HBAN

ROLLINS JAMES D III sold $3.9M of HBAN

ROLLINS JAMES D III sold 223,522 shares of HUNTINGTON BANCSHARES INC /MD/ (HBAN) at $17.35 ($3.88M total) on 2026-06-12.

Original reporting
SEC EDGAR · ROLLINS JAMES D III
Published Jun 16, 2026, 8:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HBAN
Neutral
medium confidence
Mentioned
$HBAN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HBANNeutralLow
01

Why it matters

This disclosure updates the record of insider ownership and may marginally influence sentiment, but it does not introduce new operating or financial information.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to change valuation without accompanying fundamental news.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says no), but it also provides no context on total compensation, prior holdings, or whether other insiders sold/bought around the same time.

Relevance 6/10Novelty 6/10Timing: filed 2026-06-16 (Form 4) for a sale dated 2026-06-12

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Huntington Bancshares (HBAN).

Company-level read

Ticker impact

$HBANNeutralMedium confidence
Context

SEC Form 4 shows director James D. Rollins sold 223,522 HBAN shares in an open-market transaction on 2026-06-12.

Expected impact

Likely limited/short-lived impact; any move would be more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan stated; however, the article provides no earnings, guidance, or operational catalyst.

Market effects

No sector-level read-across; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Director sales can be driven by diversification, taxes, or pre-planned liquidity needs rather than bearish expectations.

Key entities

  • Huntington Bancshares Inc

    HBAN, the company whose director sold shares via an open-market sale.

  • James D. Rollins III

    Director who sold 223,522 shares at $17.35 on 2026-06-12.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HBANMedAI 8/10

Huntington Bancshares 3Q 2026: Revenue $2.79B, EPS $0.33— 10-Q Summary

Huntington Bancshares reported 3Q 2026 revenue of $2.79B, up 30.8% YoY, and net income of $721M, up 14.6% YoY. EPS was $0.33, down 19.5% YoY, due to acquisition-related expenses. Growth was driven by acquisitions, organic growth, and higher net interest income. Management highlighted progress in integrating recent acquisitions and investing in technology.

$SEBMed

Sweden’s SEB pauses buybacks as Barclays plans further capital returns ahead of Basel 3.1

SEB paused buybacks due to capital buffer pressure from model adjustments and loan growth, reporting a 17.1% CET1 ratio. Barclays announced a GBP 500M buyback, expecting Basel 3.1 to reduce its CET1 ratio but maintain distribution headroom. EU agreed lower capital requirements for qualifying securitisations. Huntington Bancshares saw diverging capital ratios due to interest-rate losses. BPI's provisions fell despite worsening problem-loan metrics.

$HBANMedAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlights: Strong Fee Growth

Huntington Bancshares (HBAN) reported strong Q3 2026 results, with fee revenue up over 15% YoY and commercial loan growth driving a 1.1% increase in loan balances. The company expects 2027 EPS growth of over 20% and ROTCE of 17%-18%. However, it faces challenges like a competitive environment and slightly lowered fee revenue guidance for Q4. The bank repurchased $460 million in stock YTD and plans $1.8-$1.9 billion in buybacks for 2026-2027.

$HBANHighAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlig

Huntington Bancshares (HBAN) reported Q3 2026 earnings with net interest income up 0.9% quarter-over-quarter and 37% year-over-year. Net interest margin increased 4 basis points to 3.25%. Non-interest expense remained flat, while value-added fee revenue rose over 15% year-over-year. Loans grew 1.1% period-end, and deposits increased 0.2%. The company expects 2027 EPS growth of over 20% and plans $1.8-$1.9 billion in share repurchases through 2027.

$HBANMed

Huntington (HBAN) Q3 2026 Earnings Call Transcript

Huntington (HBAN) reported strong Q3 2026 earnings, with C&I growth driven by national commercial strategy. The company expects 2027 EPS to grow over 20% from 2025, with ROTCE in the 17-18% range. They have completed $460 million in share repurchases year-to-date and plan to return substantial capital to shareholders. Huntington's operating model combines local and national commercial banking, with $191 billion in loans and $225 billion in deposits.

$HBANMed

What Huntington Bancshares (HBAN) Said on Its Q3 Earnings Call

Huntington Bancshares (HBAN) reported Q3 earnings with net interest income at $2.1B, up 0.9% sequentially. Net interest margin increased to 3.25%, with management expecting it to remain flat in Q4. Fee revenue grew 15% YoY, and noninterest expense was stable. The company repurchased $460M of common stock YTD and expects $1.8B-$1.9B in repurchases over 2023-2024. Net charge-offs were 31 basis points, with stable credit performance.